HTD1801 for kidney function in diabetes and kidney disease
Part of Hormones & metabolism, Kidney & urinary clinical trials.
This trial tests whether a new drug, HTD1801, can protect or improve kidney function in people with type 2 diabetes and chronic kidney disease. It may help slow kidney damage and reduce protein in urine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged 18 to 75 years old
- Have both type 2 diabetes and chronic kidney disease (moderate stage)
- On a stable dose of diabetes or kidney-protective medications for at least 3 to 4 weeks
- Body mass index (BMI) between 18.5 and 40, with stable weight in the last 3 months
- Not on dialysis and no serious liver, heart, or bleeding conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new system to manage diabetic kidney disease across all stages. It is for people with type 2 diabetes who either have no kidney damage or have kidney damage confirmed by a biopsy.
This study tests a new medication (DWP16001) for people with type 2 diabetes and moderate kidney disease. It aims to see if the drug helps protect kidney health and manage blood sugar.
This trial tests an investigational drug called HRS-1780 in people with chronic kidney disease. It aims to see if the drug can help slow kidney decline and is safe to use.
This study tests a personalized medication approach to lower kidney and heart risks in people with type 2 diabetes and early-to-moderate kidney disease. It may help you if you have a high chance of heart problems and can start new medications.
This study tests new treatments to protect the heart and kidneys in people with long-standing type 1 diabetes. It aims to prevent or slow down complications like heart failure and kidney damage.
This study tests a new drug called IGT-303 for people with chronic kidney disease caused by type 2 diabetes. It aims to see if the drug is safe and can help protect kidney function.
Hear when a new CKD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.